Cargando…
Frequency of CHEK2*1100delC in New York breast cancer cases and controls
BACKGROUND: The 1100delC CHEK2 allele has been associated with a 1.4–4.7 fold increased risk for breast cancer in women carrying this mutation. While the frequency of 1100delC was 1.1–1.4% in healthy Finnish controls, the frequency of this allele in a North American control population and in North A...
Autores principales: | Offit, Kenneth, Pierce, Heather, Kirchhoff, Tomas, Kolachana, Prema, Rapaport, Beth, Gregersen, Peter, Johnson, Steven, Yossepowitch, Orit, Huang, Helen, Satagopan, Jaya, Robson, Mark, Scheuer, Lauren, Nafa, Khedoudja, Ellis, Nathan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149355/ https://www.ncbi.nlm.nih.gov/pubmed/12529183 http://dx.doi.org/10.1186/1471-2350-4-1 |
Ejemplares similares
-
CHEK2
(∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014) -
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
por: Isinger, Anna, et al.
Publicado: (2006) -
CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007) -
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
por: Massink, Maarten P. G., et al.
Publicado: (2015) -
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis
por: Koppert, L B, et al.
Publicado: (2004)